> 数据图表想问下各位网友盈利预测2025-3-3盈利预测图：三生制药产品销售收入预测（百万元）产品营业收入（百万元）YOY特比澳蔓迪赛普汀益普赛促红素CDMO及其他20216382.013080602677891120724.0120226859.437.5%33978941545121129773.4320237815.9413.9%42051124218565940763.9420249107.97816.5%506213373296241018737.9782025E10,202.3312.0%580414014306901117760.332026E11,594.9813.7%670915784987061173930.982027E12,886.3511.1%751917096028221280954.35资料来源：wind,华西证券研究所，注：收入预测中未考虑未来潜在新增 BD 收入图：可比公司估值（对应2025年3月26日收盘价）代码证券简称1530.HK三生制药可比公司平均值1093.HK1177.HK3692.HK2096.HK2696.HK中国生物制药翰森制药先声药业复宏汉霖石药集团总收入(百万元)归母净利润(百万元)市盈率PE24A25E26E24A25E26E9107.9810202.3311594.982090.322389.242670.4528866.1612260.816635.215724.4532552.613293.497767.65619036475.9814701.428811.6564943499.834371.82733.16820.473724.714305.811192.329014186.194634.851464.65960/30817.3333012.29/5239.445635.5724A7.0716.68 15.9121.7322.6614.548.5825E9.86 16.99 16.7526.7214.617.339.5426E8.82 15.35 14.924.8211.8916.258.87资料来源：wind,华西证券研究所27华西证券综合其他
